Evangelia Farmaki

Prof. Dr. Evangelia Farmaki

orcid

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2014 in Journal of Allergy and Clinical Immunology
Verified
Journal Article
Closed access
BGBenjamin Gathmann
Benjamin Gathmann
NMNizar Mahlaoui
Nizar Mahlaoui
LGLaurence Gérard
Laurence Gérard
EOEric Oksenhendler
Eric Oksenhendler
KWKlaus Warnatz
Klaus Warnatz
BGBodo Grimbacher
Bodo Grimbacher

1 April 2017 in Journal of Allergy and Clinical Immunology
Verified
Journal Article
Closed access
MMM. Teresa de la Morena
M. Teresa de la Morena
DLDavid Leonard
David Leonard
TTTroy R. Torgerson
Troy R. Torgerson
OMOtavio Marques
Otavio Marques
MSMary Slatter
Mary Slatter
CRChaim M. Roifman
Chaim M. Roifman

16 September 2004 in European Journal of Clinical Microbiology & Infectious Diseases
Verified
Journal Article
Closed access
PDF file
Emmanuel RoilidesEmmanuel Roilides
Emmanuel Roilides
EFEvangelia Farmaki
Evangelia Farmaki
JEJ. Evdoridou
J. Evdoridou
JDJ. Dotis
J. Dotis
EHE. Hatziioannidis
E. Hatziioannidis
GKG. Kremenopoulos
G. Kremenopoulos

1 April 2010 in The Journal of Pediatrics
Verified
Journal Article
Closed access
EMElpis Mantadakis
Elpis Mantadakis
EFEvangelia Farmaki
Evangelia Farmaki
GBGeorge R. Buchanan
George R. Buchanan

1 November 2002 in Journal of Hospital Infection
Verified
Journal Article
Closed access
PDF file
PPParaskevi Panagopoulou
Paraskevi Panagopoulou
JFJ. Filioti
J. Filioti
GPG. Petrikkos
G. Petrikkos
PGP. Giakouppi
P. Giakouppi
MAM. Anatoliotaki
M. Anatoliotaki
ERE. Roilides
E. Roilides

1 February 2003 in Journal of Clinical Microbiology
Verified
Journal Article
Closed access
PDF file
EREmmanuel Roilides
Emmanuel Roilides
EFEvangelia Farmaki
Evangelia Farmaki
JEJoanna Evdoridou
Joanna Evdoridou
AFAndrea Francesconi
Andrea Francesconi
MKMiki Kasai
Miki Kasai
TWThomas Walsh
Thomas Walsh
From June to July 1998, two episodes of Candida tropicalis fungemia occurred in the Aristotle University neonatal intensive care unit (ICU). To investigate this uncommon event, a prospective study of fungal colonization and infection was conducted. From December 1998 to December 1999, surveillance cultures of the oral cavities and perinea of the 593 of the 781 neonates admitted to the neonatal ICU who were expected to stay for >7 days were performed. Potential environmental reservoirs and possible risk factors for acquisition of C. tropicalis were searched for. Molecular epidemiologic studies by two methods of restriction fragment length polymorphism analysis and two methods of random amplified polymorphic DNA analysis were performed. Seventy-two neonates were colonized by yeasts (12.1%), of which 30 were colonized by Candida albicans , 17 were colonized by C. tropicalis , and 5 were colonized by Candida parapsilosis . From December 1998 to December 1999, 10 cases of fungemia occurred; 6 were due to C. parapsilosis , 2 were due to C. tropicalis , 1 was due to Candida glabrata , and 1 was due to Trichosporon asahii (12.8/1,000 admissions). Fungemia occurred more frequently in colonized than in noncolonized neonates ( P < 0.0001). Genetic analysis of 11 colonization isolates and the two late blood isolates of C. tropicalis demonstrated two genotypes. One blood isolate and nine colonization isolates belonged to a single type. The fungemia/colonization ratio of C. parapsilosis (3/5) was greater than that of C. tropicalis (2/17, P = 0.05), other non- C. albicans Candida spp. (1/11, P = 0.02), or C. albican s (0/27, P = 0.05). Extensive environmental cultures revealed no common source of C. tropicalis or C. parapsilosis . There was neither prophylactic use of azoles nor other risk factors found for acquisition of C. tropicalis except for total parenteral nutrition. A substantial risk of colonization by non- C. albicans Candida spp. in the neonatal ICU may lead to a preponderance of C. tropicalis as a significant cause of neonatal fungemia.